Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings.

Radiology

From the Department of Radiology (A.C., C.M., A.Y., A.O., G.S.K.), Sanford J. Grossman Center of Excellence in Prostate Imaging and Image Guided Therapy (A.C., A.Y., A.O., G.S.K.), Human Tissue Resource Center (B.H.), Department of Pathology (T.A.), and Section of Urology, Department of Surgery (S.E.), University of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637; and Discipline of Medical Imaging Science, Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia (R.M.B.).

Published: February 2022

Background Tissue estimates obtained by using microstructure imaging techniques, such as hybrid multidimensional (HM) MRI, may improve prostate cancer diagnosis but require histologic validation. Purpose To validate prostate tissue composition measured by using HM MRI, with quantitative histologic evaluation from whole-mount prostatectomy as the reference standard. Materials and Methods In this HIPAA-compliant study, from December 2016 to July 2018, prospective participants with biopsy-confirmed prostate cancer underwent 3-T MRI before radical prostatectomy. Axial HM MRI was performed with all combinations of echo times (57, 70, 150, and 200 msec) and values (0, 150, 750, and 1500 sec/mm). Data were fitted by using a three-compartment signal model to generate volumes for each tissue component (stroma, epithelium, lumen). Quantitative histologic evaluation was performed to calculate volume fractions for each tissue component for regions of interest corresponding to MRI. Tissue composition measured by using HM MRI and quantitative histologic evaluation were compared (paired test) and correlated (Pearson correlation coefficient), and agreement (concordance correlation) was assessed. Receiver operating characteristic curve analysis for cancer diagnosis was performed. Results Twenty-five participants (mean age, 60 years ± 7 [standard deviation]; 30 cancers and 45 benign regions of interest) were included. Prostate tissue composition measured with HM MRI and quantitative histologic evaluation did not differ (stroma, 45% ± 11 vs 44% ± 11 [ = .23]; epithelium, 31% ± 15 vs 34% ± 15 [ = .08]; and lumen, 24% ± 13 vs 22% ± 11 [ = .80]). Between HM MRI and histologic evaluation, there was excellent correlation (Pearson : overall, 0.91; stroma, 0.82; epithelium, 0.93; lumen, 0.90 [all < .05]) and agreement (concordance correlation coefficient: overall, 0.91; stroma, 0.81; epithelium, 0.90; and lumen, 0.87). High areas under the receiver operating characteristic curve obtained with HM MRI (0.96 for epithelium and 0.94 for lumen, < .001) and histologic evaluation (0.94 for epithelium and 0.88 for lumen, < .001) were found for differentiation between benign tissue and prostate cancer. Conclusion Tissue composition measured by using hybrid multidimensional MRI had excellent correlation with quantitative histologic evaluation as the reference standard. © RSNA, 2021 See also the editorial by Muglia in this issue.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805656PMC
http://dx.doi.org/10.1148/radiol.2021204459DOI Listing

Publication Analysis

Top Keywords

histologic evaluation
28
tissue composition
20
quantitative histologic
20
composition measured
16
prostate tissue
12
hybrid multidimensional
12
multidimensional mri
12
prostate cancer
12
measured mri
12
mri quantitative
12

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!